Therapeutic Group

Indication Dosage

Proglumide is a drug that acts as a cholecystokinin antagonist, which means it blocks the effects of the hormone cholecystokinin in the body. It was originally developed as an anti-ulcer drug but has also been investigated for its potential to treat opioid addiction and enhance memory. Proglumide has been shown to reduce the severity of withdrawal symptoms in opioid-dependent individuals and to enhance memory in animal studies. However, its use in humans for these purposes is still experimental and not widely accepted.

Duodenal Ulcer, Gastritis, And Other Gastric Secretions: 

• Adults: 800 Mg To 1200 Mg Daily In 2-3 Divided doses. 
• Children: Not Recommended.

Content

Pregnancy

Caution Advised

Stability

Contra Indications

Precautions

Lactation

Side Effects